Diego Rey
FounderFounder/CSO at Endpoint Health
San Francisco, California
Writes $50K – $1M checks · typically $50K
FoundedEndpoint Health · YC
Find your path to Diego
3,445 people in our graph share verified history with Diego — schools, employers, funds. One of them is your warm intro.
About
Diego Rey is the Chief Executive Officer of Gemini Therapeutics, a company developing aldoxorubicin, a tumor-targeted chemotherapy that has completed 16 clinical trials and received five orphan drug designations. He previously co-founded GeneWEAVE Biosciences, where he served as Chief Technology Officer and is named as author on 27 issued patents, and co-founded Endpoint Health, serving as Chief Scientific Officer and board member. Rey holds a BS in Electrical Engineering from UC Santa Barbara and a PhD from Cornell University, was the first Visiting Partner focused on life sciences and healthcare at Y Combinator, and serves on the Cornell University College of Engineering Council.
Founder/CSO at Endpoint HealthYC W19
Intro paths
Diego went through Y Combinator (Winter 2019) — any YC alum in your network can reach them through the YC community.
In turn, Diego can intro founders to Endpoint Health's investors below.
Endpoint Health's investors · 5
Co-founders at Endpoint Health
Experience
- Gemini TherapeuticsChief Executive Officercurrent2025 — presentSan Francisco, California, United States
- Endpoint VenturesAngel investingcurrent2018 — presentSan Francisco Bay Area
- ENDPOINT HEALTHCo-Founder & Chief Scientific Officer2018 — 2024Palo Alto, CA
- Y CombinatorExpert/Part time Partner2018 — 2021San Francisco Bay Area
- Y CombinatorVisiting Partner2017 — 2018San Francisco Bay Area
- Roche Molecular SystemsHead of Research, GeneWEAVE Division of Roche Molecular Systems2015 — 2017Los Gatos, CA
- GeneWEAVECo-Founder & Chief Technology Officer2010 — 2015Los Gatos, CA
- Batt Research GroupGraduate Research Assistant2004 — 2010Tompkins County, New York, United States
Skills & more
+12 more
Technology TransferProduct DevelopmentPatentsBiochemistryCell CultureMicroscopyNanofabricationDrug DiscoveryCharacterizationDue DiligenceIntellectual PropertyLife SciencesLanguages Spanish
From Diego's professional profile.
Frequently asked questions
- Who is Diego Rey?
- Diego Rey is the Chief Executive Officer of Gemini Therapeutics, a company developing aldoxorubicin, a tumor-targeted chemotherapy that has completed 16 clinical trials and received five orphan drug designations. He previously co-founded GeneWEAVE Biosciences, where he served as Chief Technology Officer and is named as author on 27 issued patents, and co-founded Endpoint Health, serving as Chief Scientific Officer and board member. Rey holds a BS in Electrical Engineering from UC Santa Barbara and a PhD from Cornell University, was the first Visiting Partner focused on life sciences and healthcare at Y Combinator, and serves on the Cornell University College of Engineering Council.
- Where does Diego Rey work?
- Diego Rey is Founder/CSO of Endpoint Health.
- What check size does Diego Rey write?
- Diego Rey typically writes checks of $50K – $1M.
- What companies did Diego Rey found?
- Diego Rey founded Endpoint Health.
- Where did Diego Rey go to school?
- Diego Rey studied at Cornell University (MS & PhD, Biomedical Engineering); UC Santa Barbara (BS, with Honors); Palo Alto High School.
Founder mafias
Y Combinator mafia10,230
Also came through, then founded or led a company.
+ 10,223 more
Cornell mafia535
Also came through, then founded or led a company.
+ 528 more
UC Santa Barbara mafia179
Also came through, then founded or led a company.
+ 172 more
Palo Alto High School mafia12
Also came through, then founded or led a company.
+ 5 more
Same school
Also attended Cornell University1,397
+ 1,391 more
Also attended UC Santa Barbara489
+ 483 more
Also attended Palo Alto High School34
+ 28 more
Also attended Lake Tahoe Community College2
Shared employers
Also worked at Gemini Therapeutics3
Also worked at ENDPOINT HEALTH4
Also worked at Y Combinator429
+ 423 more
Also worked at Roche Molecular Systems224
+ 218 more
























































